Trioxasalen 25 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Trioxasalen 25 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Furocoumarin photosensitiser (PUVA therapy)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Trioxasalen 25 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Trioxasalen 25 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Trioxasalen 25 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Trioxasalen 25 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Vitiligo (oral PUVA / PUVAsol)
- Psoriasis (resistant cases)
- Cutaneous T-cell lymphoma (early stages)
Mechanism of Action
Trioxsalen intercalates between DNA base pairs. On UVA exposure (320–400 nm), it forms covalent cross-links with thymine on opposite DNA strands, halting DNA synthesis in dividing cells. In vitiligo, it stimulates melanocyte repopulation; in psoriasis it suppresses hyperproliferative keratinocytes.
Dosage & Administration
- Adult: 25–50 mg 2 hours before controlled UVA exposure
- Use protective UV eyewear 24 hours after dose
- Therapy under specialist dermatologist supervision only
Side Effects
- Nausea
- Phototoxic burn if UVA dose excessive
- Cataract (long-term — eye protection mandatory)
- Increased risk of squamous cell carcinoma (long-term)
- Hepatotoxicity (rare)
Contraindications
- History of skin cancer
- Photosensitive disorders
- Severe hepatic impairment
- Pregnancy and breastfeeding
- Children
- Aphakia
Storage
Store below 25°C, protect from light.
PCD Pharma Franchise for Trioxasalen 25 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Trioxasalen 25 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Trioxasalen 25 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Trioxasalen 25 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Trioxasalen 25 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Trioxasalen 25 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Trioxasalen 25 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Trioxasalen 25 mg Tablet?
Available pack sizes include: 10 x 10 (Alu alu).
What is the MRP / trade price for Trioxasalen 25 mg Tablet?
MRPs range from ₹1100 to ₹1100 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Trioxasalen 25 mg Tablet?